Drug: LAMOTRIGINE. Injury: Generalised erythema Quarter: 2016Q3
Total Records: 17 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
84725494 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160826 | JP |
85263095 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 30.79 YR | M | 0 | 20160818 | JP |
88887143 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 63.83 YR | F | 0 | 20160818 | JP |
89584035 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 16.82 YR | M | 0 | 20160818 | JP |
89776352 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 41.78 YR | F | 0 | 20160818 | JP |
91209155 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 50.67 YR | F | 0 | 20160818 | JP |
93586692 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 17.63 YR | F | 0 | 20160822 | JP |
93936585 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 51.23 YR | M | 0 | 20160822 | JP |
95267956 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 46.15 YR | M | 0 | 20160826 | JP |
96243792 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 37.55 YR | M | 0 | 20160822 | JP |
98567173 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 43.30 YR | F | 0 | 20160822 | JP |
103967339 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 65.75 YR | F | 0 | 20160708 | JP |
104165364 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 25.27 YR | F | 0 | 20160822 | JP |
126367561 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 29.67 YR | F | 0 | 20160809 | JP |
126704391 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 31.16 YR | F | 0 | 20160822 | JP |
126915921 | LAMOTRIGINE. | Generalised erythema | GLAXOSMITHKLINE | 68.95 YR | F | 45 KG | 20160826 | JP |
127033851 | LAMOTRIGINE. | Generalised erythema | APOTEX | 52.00 YR | M | 0 | 20160831 | JP |
Total Records: 17 Number of Pages: 1